JG
Jason Gardner
See RemarksDirector

Jason Gardner insider trades: Magenta Therapeutics (MGTA) stock buys and sales

See Remarks, Magenta Therapeutics Last trade Sep 16, 2021 18 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2018
1
Company
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jason reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 16, 2021MGTA↓ Sell$97K
Jan 10, 2020MGTA↓ Sell$171K
Jan 2, 2020MGTA↓ Sell$42K
Dec 23, 2019MGTA↓ Sell$44K
Dec 20, 2019MGTA↓ Sell$1.2M
Dec 10, 2019MGTA↓ Sell$66K
Jun 21, 2019MGTA↓ Sell$212K
Jun 25, 2018MGTA↑ Buy$6K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jason Gardner's insider trades

Jason Gardner is See Remarks at Magenta Therapeutics (MGTA). Since Jun 25, 2018, Jason has reported 1 open-market purchase worth $6K and 7 sales worth $1.8M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (10 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MGTA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.